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Abstract The growth arrest-specific gene gas6 encodes a 
secreted protein (Gas6) which is a member of the vitamin In-
dependent protein family and was identified as a ligand for the 
Axl tyrosine kinase receptor family. Gas6 shares significant 
similarity with protein S and a similar domain organisation: an 
extensively γ-carboxylated amino-terminal, four epidermal 
growth factor-like motifs and a large carboxy-terminal region, 
known as the D domain. Here we report on the isolation of a 
splice variant (gas6SV) characterised by an in-frame 129 bp 
insertion between the fourth EGF domain and the D domain. The 
gene gas6 was previously mapped on chromosome 13. The 
genomic organisation of gas6 has been investigated demonstrat-
ing the presence of alternative splicing consensus sites. Expres-
sion of gas6SV has been investigated in various human tissues 
and found to have a similar distribution pattern as gas6, with the 
exception of the spleen where gas6SV seems to be the 
predominant form. 
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1. Introduction 
The gas6 product (Gas6) has been identified as a new mem-
ber of the vitamin K-dependent family of proteins [1], with a 
significant degree of amino acid identity to human protein S, a 
negative co-regulator in the coagulation pathway [2]. Both 
human and murine gas6 have been characterised and revealed 
a high degree of amino acid conservation (81% amino acid 
identity) [1]. A rat gasó homologue was identified as a growth-
potentiating factor for smooth muscle cells [3]. Similarly to 
protein S, Gas6 shows several defined structural motifs: a γ-
carboxylated amino-terminus (Gla domain), four epidermal 
growth factor (EGF)-like repeats and a large carboxy-termi-
nal region with similarity to steroid-binding globulin. Gas6 
lacks the consensus domain recognised by thrombin which is 
involved in the regulation of the biological activity in protein 
S [1,2]. 
Recently, the human gas6 gene has been assigned to chro-
mosome 13, region q34 [4], where also the vitamin K-depend-
ent proteins factor VII and X have been previously mapped 
[5], thus defining a distinct localisation with respect to protein 
S gene that has been mapped in the centromeric region 
(pll.l—ql 1.2) of chromosome 3. gasó is widely expressed in 
many tissues and quite abundantly in lung, intestine and en-
dothelium, while it is almost undetectable in the liver, where 
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protein S can be detected at high levels [1,6]. Human Gas6 
was shown to act as the ligand for a family of tyrosine kinase 
receptors with transforming activities: Axl [7], Rse [8] and 
Mer [9]. We have previously reported that Gas6 is able to 
induce cell cycle re-entry and protect serum-starved NIH3T3 
cells from cell death by apoptosis and that such activities 
require the activation of a PI3K-dependent pathway [10,11]. 
Here we describe the identification and expression pattern of a 
gasó splice variant (gas6SV) potentially encoding a protein 
containing an additional 43 amino acid peptide linking the 
fourth EGF domain and the C-terminal D domain. 
2. Materials and methods 
2.1. Isolation of cDNA clones for human gas6 
A HeLa cDNA library generated in λ vector 1149 was screened as 
reported [1]. Of the two cDNA clones isolated, one represented the 
reported cDNA [1], while the other represents the splice variant de-
scribed here. 
2.2. Isolation of human gas6 genomic clones 
Filters of a cosmid human genomic library specific for chromosome 
13 [12] were kindly provided from Reference Library Data Base 
(RLDB), Imperial Cancer Research Foundation (ICRF). 
gasó cDNA restriction fragments were labelled with [a32P]dCTP 
using random priming at a specific activity of 1X108 cpm^ig and 
hybridisation was carried out at 42°C for 18 h, with 1 X106 cpm/ml 
in 50% formamide, 4XSSC (standard sodium citrate), 10% dextran 
sulphate, 1% SDS (sodium dodecyl sulphate), lOxDenhardt's solu-
tion, 50 mg/ml denatured salmon sperm DNA, 1 mM EDTA (pH 8) 
and 50 mM sodium phosphate (pH 7). Washes were performed at 
high stringency, once for 15 min in 2XSSC, 1% SDS at 55°C and 
twice for 30 min in 0.2XSSC, 0.1% SDS at 60°C. 
2.3. PCR amplification 
The reaction was carried out in an Air Thermal Cycler (Idaho) 
using two primers mapping respectively at nt 924-941 and nt 1139-
1156, as shown in Fig. 1. After 3 min of denaturation (94°C), 30 
cycles were performed under these conditions and order: 10 s at 
94°C, 10 s at 60°C, 20 s at 72°C. In the last cycle, elongation time 
was prolonged to 5 min. PCR product was subcloned in pBluescript 
(Stratagene) and sequenced. 
2.4. DNA sequence and analysis 
The nucleotide sequence was determined by the dideoxy-chain ter-
mination method [13], with the T7 sequencing kit (Pharmacia). Spe-
cific synthetic oligonucleotides were used as primers for the sequenc-
ing reactions. 
Sequences of cDNA clones was obtained using the EMBL-ALF 
sequencer, whereas genomic clones and radioactive sequencing reac-
tions were run on ultra-thin polyacrylamide gels [14]. Sequence anal-
ysis was performed using the IntelliGenetics software package. 
2.5. RT-PCR expression analysis 
Reverse transcription was performed on 6 μg of total RNA ex-
tracted from different tissues [15], using oligodT [16-18] as a primer 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)01094-6 
P. Marcandalli et al.lFEBS Letters 415 (1997) 56-58 57 
Fig. 1. Sequence analysis of the GasóSV insertion. A: Gas6SV cDNA organisation after Manfloletti et al. [1]. The dotted white line indicates 
the GasóSV γ-carboxylated domain (Gla) which is followed by the short linker region B (square-hatched) and the four EGF repeats containing 
domain C (hatched). The black line indicates the 129 bp sequence of the Gas6SV insertion, while the grey line represent the large C-terminal D 
domain. B: Sequence of the 129 bp in-frame insertion is shown in bold. Both nucleotide (upper lines) and amino acid (lower lines) sequences 
are shown. The last codons of region C and first codons of region D common to both gasó and gas6SV are shown. 
and M-MLV Reverse Transcriptase (BRL). One tenth of each reac-
tion was then used for amplifications with two different primer pairs, 
the first one specific for the insertion (nt 1-18 and nt 112-129) and the 
second one mapping in the D region (nt 1100-1116 and nt 1255-
1272), as shown in Fig. 2. As a negative control for PCR, the same 
reaction mixture with no M-MLV Reverse Transcriptase added was 
used. After 2 min of denaturation (94°C), 35 cycles were performed in 
the following conditions: 8 s at 94°C, 10 s at 60°C for the first primers 
pair and 57°C for the second one, 10 s at 72°C. In the last cycle, the 
elongation time was prolonged to 5 min. Samples were run on a 2.5% 
agarose gel, blotted [15] and filters were hybridised with the same 
probe, constituted by a fragment of the splice variant cDNA spanning 
from the Sad site in position 698 to the whole 3' UTTER. This 
fragment was labelled as described above and hybridised for 18 h at 
65°C in 1 M NaCl, 1% SDS, 100 mg/ml denatured salmon sperm 
DNA and 5 XDenhardt's solution. Filters were washed at 65°C, twice 
in 2XSSC, 0.1% SDS for 15 min and once in 0.2XSSC, 0.1% SDS for 
30 min. 
3. Results and discussion 
The original screening that allowed isolation of gasó [1] also 
revealed the existence of an additional c D N A encoding a 
splicing variant for human gasó (gasóSV). Sequence analysis 
indicated that this c D N A is 2627 bp long and encodes a 716 
amino acid protein. This splicing variant form shows a c D N A 
organisation similar to that of the previously characterised 
gas6 [1] except for an in-frame 129 bp insertion between the 
regions encoding the fourth EGF-l ike and the D domain (Fig. 
1). This insertion encodes a 43 amino acid sequence that does 
not show significant similarity to any known sequence stored 
in the SwissProt data bank. In order to assess the presence of 
the respective splice junct ion consensus sequences the genomic 
organisation of the region surrounding this insertion was an-
alysed. A human cosmid library specific for chromosome 13, 
where the human gas6 gene had previously been mapped [4], 
was screened with two different probes, corresponding respec-
tively to the 5 ' (nt 1-1000) and the 3 ' (nt 1001-2461) port ions 
of the gas6 c D N A sequence, as reported in Gene Bank 84. A 
cosmid clone (ICRFcl08P1847) positive both for the 5' and 
the 3 ' gas6 c D N A probes was selected for further character-
isation. In order to isolate only the region of interest, P C R 
was performed using two primers based on the fourth E G F -
like repeat and the D region of the gas6 sequence respectively, 
as reported in Fig. 2. Amplified products were run on agarose 
gel and transferred onto nylon membrane. After hybridisation 
with an insertion-specific probe, a single band of about 2000 
bp was recognised. The same pat tern was also obtained with 
two other independent clones isolated from the same screen-
ing ( ICRFcl08L0128 and ICRFcl08G072) . The amplified ge-
nomic fragment was subcloned and sequenced. The intron/ 
exon organisation of this region indicates that the 129 bp 
insertion present in the gasóSV c D N A is included in the 
exon-containing 5' sequence of region D (Fig. 2). This exon 
is separated from the upstream exon, encoding the fourth 
Region C 
ACGGGCGTGGGGGCCTCAA--CCTGTGAG 
TGCCCGCACCCCCGGACTT- -GGACACTC 
intron (~J800 bp) IN FRAME INSERTION 
GTAGGCGGC TCTCAGCAG 
Region D 
CATCCGCCG AGAGTCGTC 
CTAGAGGCGG 
GATCTCCGCC 
GTCCGTGGCAG 
CAGGCACCGTC 
G A C A T O - TCTTTGCCGGAGGCCACCA 
C T G T A G - - AGAAACGGCCTCCGGTGGT 
b __ - -
Fig. 2. Genomic organisation of the gasó gene region surrounding the insertion. Two different transcripts originate from an alternative splicing 
that either comprises or excludes the 129 bp insertion (as shown by dashed lines): a: excision of the 1800 bp intron generates the gas6SV 
form; b: when the insertion is also spliced as part of the intron, the previously characterised gasó shorter form is obtained [1], Splice donor 
and acceptor site sequences are indicated in bold. Position of the oligonucleotides used for the region amplification is marked by bold lines. 
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Fig. 3. Expression analysis of gas6SV. A: Position of the two pri-
mer pairs used for reverse transcription PCR (RT-PCR). The first 
pair (a and a') maps within the insertion, allowing specific amplifi-
cation of gasóSV mRNA. The second pair (b and b') maps in a re-
gion present both in gasó and GasóSV transcripts, and has been 
used to asses the total gas6 mRNA content in each tissue. B: 
Southern blotting of RT-PCR performed on equal amounts of total 
RNA from the indicated human tissues, using primers a and a'. A 
single band of 129 bp was obtained. C: The same RT reaction mix-
tures were used for PCR with primers b and b' and analysed by 
Southern blot as above. A single band of 172 bp representative of 
both gas6 and gasóSV was obtained. In both filters a negative con-
trol (PCR performed without adding template cDNA) was included. 
EGF-like domain of region C, by an intron of about 1800 bp. 
The 5' splice junction matches the canonical consensus se-
quence [17], while two different putative splice sites are 
present at the 3'. The first one is located in the 5' region of 
the insertion and has a weaker consensus than the following 
one, as shown in Fig. 2. This genomic organisation therefore 
allows two alternative transcription products, in which the 129 
bp insertion can be either comprised (GasóSV) or excluded 
(Gas6). The tissue distribution of Gas6 has already been re-
ported. This transcript is expressed in lung, intestine and bone 
marrow [1]. In order to determine the expression of the 
gasóSV mRNA with respect to the total gasó mRNA, several 
human tissues were analysed by RT-PCR using two different 
sets of primers. The first one is insertion-specific (nt 1-18 and 
nt 112-129, relative to insertion sequence), while the second 
one, mapping in the D domain (nt 1099-1115 and nt 1254— 
1271) is common to both transcripts (Fig. 3). Consistent with 
the previous Northern blot analysis [1], gasó mRNA was 
found to be expressed at rather high levels in most of the 
tissues investigated with the exception of the liver (see Fig. 
3B). A similar pattern of expression, albeit at significantly 
lower levels, was shown for the gasóSV (Fig. 3C). In spleen, 
however, the signal detected after amplification of the sole 
splicing variant form was comparable to that obtained from 
the total gasó, indicating that the gasóSV form predominates 
in this tissue. Placenta (and colon, not shown) showed a low 
level of gasóSV expression; conversely, significant levels of 
gasó could be detected in these tissues. 
We have previously reported the isolation and character-
isation of the growth arrest-specific gene gasó [1]. The protein 
encoded by gasó, Gasó, was found to be a growth factor with 
mitogenic and antiapoptotic activities [10,11]. Here we report 
the isolation and the expression pattern of a gasó splice var-
iant containing an additional 129 bp in the protein open read-
ing frame. Interestingly, gasó and its receptors are widely ex-
pressed while the splice variant seems to have a more 
restricted pattern of expression. The Gla domain of Gas6, 
similarly to other Gla domains, should be involved in mem-
brane interaction [2], while the C-terminal D domain was 
found to activates both Rse [18] and Axl receptor phospho-
rylation (see accompanying manuscript). We can therefore 
hypothesise that the insertion of an additional hinge region 
could be involved in the regulation of growth factor presen-
tation. Finally, since the inserted sequence present in GasóSV 
is the target of a protease that cleaves the active D domain 
from GasóSV (see accompanying manuscript), the existence of 
splice variants could represent a role for modulation of both 
growth factor activity and availability. 
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